19don MSN
Cerebrospinal fluid biomarker improves diagnosis of Parkinson's disease and Lewy body dementia
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication in the journal Nature Medicine, they describe the discovery of a new ...
Parkinson’s disease is the second most common neurodegenerative disorder after Alzheimer’s disease. Many people still don’t fully understand the nature of Parkinson’s disease, and far less may be able ...
An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent publication, they describe the discovery of a new quantitative biomarker in lumbar ...
Global prevalence estimates show Alzheimer’s disease accounts for most dementia, with ~57 million people affected in 2021 and numbers projected to triple by 2050. People and health systems face rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results